Nitric oxide synthase

NOS research - key publications using PLN antibodies

Please rate these pages to support our infographic project:
Get free premium widgets for your blog and website.

  1. Bougaki, M. et al. 2010. Nos3 Protects against Systemic Inflammation and Myocardial Dysfunction in Murine Polymicrobial Sepsis. Shock. 34(3), pp.281-290.
  2. Buys, E.S. et al. 2007. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. American Journal of Physiology-Heart and Circulatory Physiology. 293(1), pp.H620-H627.
  3. Goette, A. et al. 2012. The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol. 154(2), pp.141-6.
  4. Loyer, X. et al. 2008. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation. 117(25), pp.3187-3198.
  5. Wang, H. et al. 2008. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. American Journal of Physiology-Cell Physiology. 294(6), pp.C1566-C1575.

Back to main infographic.

About us
meet the team
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.

Follow us on social

Contact us
We look forward to providing your favourite antibodies and kits
gender and body